ETF1 Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP6844c
Background:
ETF1 directs the termination of nascent peptide synthesis (translation) in response to the termination codons UAA, UAG and UGA.
Other Names:
Eukaryotic peptide chain release factor subunit 1, Eukaryotic release factor 1, eRF1, Protein Cl1, TB3-1, ETF1, ERF1, RF1, SUP45L1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6844c was selected from the Center region of human ETF1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ETF1
Gene ID: 2107
Primary Accession: P62495
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ETF1 directs the termination of nascent peptide synthesis (translation) in response to the termination codons UAA, UAG and UGA.
Other Names:
Eukaryotic peptide chain release factor subunit 1, Eukaryotic release factor 1, eRF1, Protein Cl1, TB3-1, ETF1, ERF1, RF1, SUP45L1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6844c was selected from the Center region of human ETF1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ETF1
Gene ID: 2107
Primary Accession: P62495
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review